CREDO BIOMEDICAL

Credo Biomedical develops, manufactures, and commercializes innovative, cost-effective, and rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of human infectious diseases, animal health, and human wellness. At Credo Biomedical, we are conscious of the necessity to simplify processes and accelerate molecular testing at lower costs. We believe that effective rapid POC Molecular Diagnostics will redefine healthcare for both human and veterinary clinical management. By providing the right information, at the right time, and to the right people, we can improve the lives of billions of people and animals around the world.